Zynerba Pharma

0 followers


Zynerba is dedicated to improving the lives of people with rare and near rare neuropsychiatric disorders where there is a high unmet medical need by pioneering the development and commercialization of next-generation pharmaceutically-produced cannabinoid therapeutics formulated for transdermal deliv... Read more

Industries

Employees

11-50

Links


Org chart

Carol O’Neill
VP, Development
Nancy Tich
VP, Clinical
Ray Mannion
VP, Manufacturing
Terry Hurst
General Manager, Australia
Paul M. Kirsch
Vice President, Regulatory Affairs And Quality Assurance
Brian Rosenberger
VP, Commercial & Business Development
Samantha Labarbera
Deputy General Counsel

Board & advisors

Warren D. Cooper
Lead Independent Director
Elizabeth M. Berry-Kravis
Scientific Advisor
Nicole Tartaglia
Scientific Advisor
Craig A. Erikson
Scientific Advisor
Steven J. Siegel
Scientific Advisor
Randi J. Hagerman
Scientific Advisor
Kathleen Angkustsiri
Scientific Advisor
Carrie Buchanan
Scientific Advisor
Tony Simon
Scientific Advisor
Helen Heussler
Scientific Advisor